应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
00874 白云山
已收盘 05-13 16:08:12
16.860
-0.090
-0.53%
最高
16.970
最低
16.750
成交量
126.40万
今开
16.960
昨收
16.950
日振幅
1.30%
总市值
274.14亿
流通市值
37.08亿
总股本
16.26亿
成交额
2,128万
换手率
0.57%
流通股本
2.20亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
白云山(00874):天心制药获得注射用头孢呋辛钠0.5g坎地沙坦酯片4mg《药品补充申请批准通知书》
智通财经 · 05-11 17:33
白云山(00874):天心制药获得注射用头孢呋辛钠0.5g坎地沙坦酯片4mg《药品补充申请批准通知书》
每周股票复盘:白云山(600332)董事会换届及年度股东会召开
证券之星 · 05-10
每周股票复盘:白云山(600332)董事会换届及年度股东会召开
白云山(600332)披露2025年年度股东会通知,5月7日股价下跌0.09%
证券之星 · 05-07
白云山(600332)披露2025年年度股东会通知,5月7日股价下跌0.09%
白云山(00874):建议重选及选举董事
智通财经 · 05-07
白云山(00874):建议重选及选举董事
白云山4月股份变动月报表:股本维持不变
公告速递 · 05-07
白云山4月股份变动月报表:股本维持不变
每周股票复盘:白云山(600332)Q1净利降2.06%
证券之星 · 05-02
每周股票复盘:白云山(600332)Q1净利降2.06%
白云山(00874)一季度归母净利润17.84亿元 同比减少2.06%
智通财经 · 04-27
白云山(00874)一季度归母净利润17.84亿元 同比减少2.06%
岭南控股:管理广州白云山鸣春谷和月溪书院等广东省内景区项目
证券之星 · 04-24
岭南控股:管理广州白云山鸣春谷和月溪书院等广东省内景区项目
白云山:2025年净利润同比增长5.21%
南方财经网 · 04-22
白云山:2025年净利润同比增长5.21%
每周股票复盘:白云山(600332)王老吉大健康获高新企业重新认定
证券之星 · 04-19
每周股票复盘:白云山(600332)王老吉大健康获高新企业重新认定
白云山(600332)披露子公司通过高新技术企业认定公告,4月16日股价下跌0.35%
证券之星 · 04-16
白云山(600332)披露子公司通过高新技术企业认定公告,4月16日股价下跌0.35%
白云山最新公告:子公司王老吉大健康获重新认定为高新技术企业
证券之星 · 04-15
白云山最新公告:子公司王老吉大健康获重新认定为高新技术企业
白云山:公司保障性租赁住房暨人才公寓建设项目目前在再论证阶段
每日经济新闻 · 04-07
白云山:公司保障性租赁住房暨人才公寓建设项目目前在再论证阶段
股市必读:白云山(600332)4月3日披露最新机构调研信息
证券之星 · 04-07
股市必读:白云山(600332)4月3日披露最新机构调研信息
每周股票复盘:白云山(600332)2025年净利增5.21%
证券之星 · 04-05
每周股票复盘:白云山(600332)2025年净利增5.21%
白云山:公司已聘请第三方机构探索制定薪酬绩效优化方案
证券日报 · 04-03
白云山:公司已聘请第三方机构探索制定薪酬绩效优化方案
白云山:未来五年公司将坚持现代化、科技化、数字化、国际化发展方向
证券日报 · 04-03
白云山:未来五年公司将坚持现代化、科技化、数字化、国际化发展方向
营收微增难掩现金流“失血”:广药白云山隐现三大结构性风险
新浪证券 · 04-03
营收微增难掩现金流“失血”:广药白云山隐现三大结构性风险
小摩增持白云山(00874)约14.39万股 每股作价约16.89港元
智通财经网 · 04-02
小摩增持白云山(00874)约14.39万股 每股作价约16.89港元
白云山(00874):白云山制药总厂获国家药监局核准签发关于骨化三醇软胶囊的《药品补充申请批准通知书》
智通财经 · 04-01
白云山(00874):白云山制药总厂获国家药监局核准签发关于骨化三醇软胶囊的《药品补充申请批准通知书》
加载更多
公司概况
公司名称:
白云山
所属市场:
SEHK
上市日期:
--
主营业务:
广州白云山医药集团股份有限公司是一家主要从事医药健康业务的中国公司。该公司通过四个分部运营。大南药分部从事中西成药、化学原料药、生物医药和天然药物等的研发、制造与销售。大健康分部从事饮料、食品、保健品等产品的生产、研发与销售。大商业分部从事医药产品、医疗器械、保健品等的批发、零售与进出口业务。大医疗分部从事医疗服务、中医养生、现代养老以及医疗器械产业的投资。该公司主要在中国国内和海外市场开展业务。
发行价格:
--
{"stockData":{"symbol":"00874","market":"HK","secType":"STK","nameCN":"白云山","latestPrice":16.86,"timestamp":1778659692003,"preClose":16.95,"halted":0,"volume":1264000,"delay":0,"changeRate":-0.005309734513274328,"floatShares":219900000,"shares":1626000000,"eps":2.1172292053348367,"marketStatus":"已收盘","change":-0.09,"latestTime":"05-13 16:08:12","open":16.96,"high":16.97,"low":16.75,"amount":21283032,"amplitude":0.012979,"askPrice":16.86,"askSize":22000,"bidPrice":16.81,"bidSize":24000,"shortable":3,"etf":0,"ttmEps":2.090617884140372,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1778722200000},"marketStatusCode":5,"adr":0,"listingDate":878140800000,"exchange":"SEHK","adjPreClose":16.95,"dividendRate":0.051934,"openAndCloseTimeList":[[1778635800000,1778644800000],[1778648400000,1778659200000]],"volumeRatio":1.009768,"lotSize":2000,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"600332","market":"SH","secType":"STK","nameCN":"白云山","latestPrice":22.85,"timestamp":1778655600000,"preClose":22.96,"halted":0,"volume":9425800,"delay":0,"premium":"-36.05"}},"requestUrl":"/m/hq/s/00874","defaultTab":"news","newsList":[{"id":"2634886402","title":"白云山(00874):天心制药获得注射用头孢呋辛钠0.5g坎地沙坦酯片4mg《药品补充申请批准通知书》","url":"https://stock-news.laohu8.com/highlight/detail?id=2634886402","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634886402?lang=zh_cn&edition=full","pubTime":"2026-05-11 17:33","pubTimestamp":1778492035,"startTime":"0","endTime":"0","summary":"智通财经APP讯,白云山(00874)公布,近日,公司子公司广州白云山天心制药股份有限公司(以下简称“天心制药”)收到国家药品监督管理局签发的注射用头孢呋辛钠0.5g(按C16H16N4O8S计)、坎地沙坦酯片4mg《药品补充申请批准通知书》。天心制药本次获得注射用头孢呋辛钠0.5g(按C16H16N4O8S计)、坎地沙坦酯片4mg《药品补充申请批准通知书》,表明上述药品的杂质药学研究获认可,有利于提升上述产品的质量控制能力和市场竞争力。本次获得上述《药品补充申请批准通知书》,对本公司当期业绩无重大影响。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1440233.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0012","01477","BK0239","BK0096","BK0183","BK1197","BK0196","BK1191","BK0188","BK0028","BK0097","BK0175","BK1574","BK0070","00874","600332","BK1521","BK1515","BK1606"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634412268","title":"每周股票复盘:白云山(600332)董事会换届及年度股东会召开","url":"https://stock-news.laohu8.com/highlight/detail?id=2634412268","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634412268?lang=zh_cn&edition=full","pubTime":"2026-05-10 03:44","pubTimestamp":1778355851,"startTime":"0","endTime":"0","summary":"截至2026年5月8日收盘,白云山报收于22.74元,较上周的22.65元上涨0.4%。本周关注点来自公司公告汇总:白云山提名新一届董事会候选人,换届选举将提交2025年年度股东会审议。会议将采用现场投票与网络投票相结合方式,审议2025年年度报告、利润分配方案、董事会换届选举、续聘会计师事务所等议案。董事会换届选举候选人任职资格已通过审核,均未持有公司股份,选举将采用累积投票制。在新一届董事会就任前,第九届董事会继续履职。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051000001508.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600332","BK0183","BK0028","BK0070","BK0096","BK0196","BK1197","BK0012","BK1515","BK0188","00874","BK1606","BK0239","BK0175","BK0097","BK1191","BK1521"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633126452","title":"白云山(600332)披露2025年年度股东会通知,5月7日股价下跌0.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2633126452","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633126452?lang=zh_cn&edition=full","pubTime":"2026-05-07 22:48","pubTimestamp":1778165295,"startTime":"0","endTime":"0","summary":"截至2026年5月7日收盘,白云山报收于22.7元,较前一交易日下跌0.09%,最新总市值为369.05亿元。近日,广州白云山医药集团股份有限公司发布《关于召开2025年年度股东会的通知》。公告显示,公司定于2026年5月29日召开2025年年度股东会,现场会议地点为广州市荔湾区沙面北街45号公司会议室,股权登记日为2026年5月22日。会议将审议2025年年度报告、利润分配方案、董事薪酬、董事会换届选举、续聘会计师事务所等议案。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050700041622.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600332","00874","BK1191","BK1197","BK0196","BK0012","BK1606","BK0188","BK1515","BK0097","BK0096","BK0175","BK0183","BK0239","BK1521","BK0070","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633400661","title":"白云山(00874):建议重选及选举董事","url":"https://stock-news.laohu8.com/highlight/detail?id=2633400661","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633400661?lang=zh_cn&edition=full","pubTime":"2026-05-07 21:15","pubTimestamp":1778159706,"startTime":"0","endTime":"0","summary":"智通财经APP讯,白云山(00874)发布公告,于2026年5月7日举行的第九届董事会第三十五次会议上,董事会审议并通过决议,同意提名下表所列董事候选人,并将提呈年度股东会审议及选举。在公司第九届董事会成员中,执行董事李小军先生及黎洪先生任期届满后将不再参与第十届董事会重选。李小军先生将退任公司董事长、执行董事、董事会战略发展与投资委员会主席等职务;黎洪先生将退任公司执行董事、董事会战略发展与投资委员会委员等职务;独立非执行董事陈亚进先生及黄民先生因已连续担任公司独立非执行董事满六年,将根据中国适用法律及公司章程,于年度股东会结束时退任,且彼等将不会于该年度股东会上膺选连任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1439244.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0183","600332","BK1515","BK0012","BK0196","BK0028","BK1606","BK0097","BK0175","00874","BK0188","BK0070","BK0239","BK0096","BK1191","BK1521","BK1197"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1175531405","title":"白云山4月股份变动月报表:股本维持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1175531405","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1175531405?lang=zh_cn&edition=full","pubTime":"2026-05-07 16:41","pubTimestamp":1778143304,"startTime":"0","endTime":"0","summary":"广州白云山医药集团股份有限公司于2026年5月7日发布截至2026年4月30日止月份的股份变动月报表。本次报告期内,公司已发行股份总数和各类别注册股本均未发生变化,股本结构保持稳定。当月无股份期权或股权激励计划相关变动,也未发生持作库存股的情况。截至2026年4月30日,白云山的注册股本总额为1,625,790,949元,保持不变。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00874"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632414686","title":"每周股票复盘:白云山(600332)Q1净利降2.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2632414686","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632414686?lang=zh_cn&edition=full","pubTime":"2026-05-02 02:31","pubTimestamp":1777660270,"startTime":"0","endTime":"0","summary":"截至2026年4月30日收盘,白云山报收于22.65元,较上周的22.52元上涨0.58%。本周,白云山4月28日盘中最高价报23.16元。本周关注点业绩披露要点:白云山2026年一季报显示,归母净利润17.84亿元,同比下降2.06%。业绩披露要点财务报告白云山2026年一季报显示,一季度公司主营收入232.78亿元,同比上升3.58%;归母净利润17.84亿元,同比下降2.06%;扣非净利润17.03亿元,同比上升1.72%;负债率53.33%,投资收益1.17亿元,财务费用8578.47万元,毛利率20.31%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050200000472.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1521","BK0175","BK0028","BK0096","BK0196","BK1197","BK0097","BK0070","00874","600332","BK1191","BK1606","BK0183","BK0012","BK0239","BK1515","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630939839","title":"白云山(00874)一季度归母净利润17.84亿元 同比减少2.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630939839","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630939839?lang=zh_cn&edition=full","pubTime":"2026-04-27 18:54","pubTimestamp":1777287274,"startTime":"0","endTime":"0","summary":"智通财经APP讯,白云山(00874)发布公告,于2026年一季度取得营业收入232.78亿元,同比增长3.58%;归属于上市公司股东的净利润17.84亿元,同比减少2.06%;基本每股收益1.097元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1434574.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["600332","00874"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629889642","title":"岭南控股:管理广州白云山鸣春谷和月溪书院等广东省内景区项目","url":"https://stock-news.laohu8.com/highlight/detail?id=2629889642","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629889642?lang=zh_cn&edition=full","pubTime":"2026-04-24 11:33","pubTimestamp":1777001594,"startTime":"0","endTime":"0","summary":"证券之星消息,岭南控股04月23日在投资者关系平台上答复投资者关心的问题。公司根据“一主多元”和“旅游+”的发展规划,设立广州广之旅悦景目的地旅游发展有限公司,目前管理广州白云山鸣春谷和月溪书院等广东省内景区项目,并将业务范围延伸至省外。其中,鸣春谷景区和月溪书院位于国家5A级景区广州白云山景区内。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042400034922.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1191","BK0239","BK0012","000524","BK0210","BK0183","BK0097","BK1606","BK0028","BK0175","BK1515","BK0188","BK1521","00874","600332","BK0196","BK1197","BK0096","BK0070","BK0173"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629809019","title":"白云山:2025年净利润同比增长5.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2629809019","media":"南方财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629809019?lang=zh_cn&edition=full","pubTime":"2026-04-22 17:05","pubTimestamp":1776848700,"startTime":"0","endTime":"0","summary":"南财智讯4月22日电,白云山(00874.HK)公告,截至2025年12月31日止年度,公司营业收入为776.56亿元人民币,同比增长3.55%;年内归属于本公司股东的净利润为29.83亿元人民币,同比增长5.21%;每股基本盈利为1.835元人民币。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202604223714114780.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["00874","600332"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628675133","title":"每周股票复盘:白云山(600332)王老吉大健康获高新企业重新认定","url":"https://stock-news.laohu8.com/highlight/detail?id=2628675133","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628675133?lang=zh_cn&edition=full","pubTime":"2026-04-19 03:27","pubTimestamp":1776540427,"startTime":"0","endTime":"0","summary":"截至2026年4月17日收盘,白云山报收于22.78元,较上周的22.92元下跌0.61%。本周,白云山4月15日盘中最高价报23.05元。本周关注点公司公告汇总:子公司王老吉大健康获高新技术企业重新认定,2025-2027年享15%所得税优惠税率公司公告汇总广州白云山医药集团股份有限公司发布公告,其子公司广州王老吉大健康产业有限公司获重新认定为国家高新技术企业,证书编号为GR202544014065,发证日期为2025年12月19日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041900001201.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0183","00874","BK0188","BK0239","BK1197","BK0070","BK0028","600332","BK0196","BK0096","BK1521","BK1191","BK1515","BK1606","BK0175","BK0012","BK0097"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627829688","title":"白云山(600332)披露子公司通过高新技术企业认定公告,4月16日股价下跌0.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2627829688","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627829688?lang=zh_cn&edition=full","pubTime":"2026-04-16 17:25","pubTimestamp":1776331502,"startTime":"0","endTime":"0","summary":"截至2026年4月16日收盘,白云山报收于22.92元,较前一交易日下跌0.35%,最新总市值为372.63亿元。该股当日开盘23.0元,最高23.0元,最低22.87元,成交额达1.93亿元,换手率为0.6%。广州白云山医药集团股份有限公司于近日发布《关于子公司通过高新技术企业认定的公告》。公告显示,其子公司广州王老吉大健康产业有限公司获重新认定为国家高新技术企业,证书编号为GR202544014065,发证日期为2025年12月19日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041600031505.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600332","BK0188","00874","BK1521","BK0096","BK0196","BK1191","BK0175","BK0028","BK0097","BK1515","BK0239","BK1197","BK1606","BK0070","BK0012","BK0183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627040731","title":"白云山最新公告:子公司王老吉大健康获重新认定为高新技术企业","url":"https://stock-news.laohu8.com/highlight/detail?id=2627040731","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627040731?lang=zh_cn&edition=full","pubTime":"2026-04-15 17:02","pubTimestamp":1776243720,"startTime":"0","endTime":"0","summary":"白云山(600332.SH)公告称,公司子公司广州王老吉大健康产业有限公司获重新认定为国家高新技术企业,证书发证日期为2025年12月19日。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041500030270.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0183","BK0028","BK0096","BK0097","BK0239","BK1197","BK0196","BK0175","600332","BK0070","00874","BK0012","BK0188","BK1515","BK1521","BK1606","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625932411","title":"白云山:公司保障性租赁住房暨人才公寓建设项目目前在再论证阶段","url":"https://stock-news.laohu8.com/highlight/detail?id=2625932411","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625932411?lang=zh_cn&edition=full","pubTime":"2026-04-07 19:06","pubTimestamp":1775559998,"startTime":"0","endTime":"0","summary":"每经AI快讯,有投资者在投资者互动平台提问:广药白云山保障性住房还在论证中,年报中还有错别字“再”,犹犹豫豫的,是不是管理层自己都认为该项投资非必要?如有必要,有没有考虑乘房地产低迷期,直接购买现房替代?白云山(600332.SH)4月7日在投资者互动平台表示,考虑到目前房地产行业情况及各方面原因,公司保障性租赁住房暨人才公寓建设项目目前在再论证阶段。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202604073696594532.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202604073696594532.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1197","600332","BK1521","BK0096","BK0196","BK0183","BK1515","BK0097","BK0188","00874","BK0012","BK0175","BK0028","BK1606","BK0070","BK0239","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625034606","title":"股市必读:白云山(600332)4月3日披露最新机构调研信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2625034606","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625034606?lang=zh_cn&edition=full","pubTime":"2026-04-07 03:23","pubTimestamp":1775503389,"startTime":"0","endTime":"0","summary":"截至2026年4月3日收盘,白云山报收于23.03元,下跌0.56%,换手率0.77%,成交量10.79万手,成交额2.48亿元。来自机构调研要点:公司天然饮品业务推进国际化,发布国际品牌标识“WLOVI”及国际罐,并在多国上市。公司暂无回购计划,后续如有将按规定披露。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040700002208.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600332","BK0188","00874","BK1521","BK0096","BK0196","BK1191","BK0175","BK0028","BK0097","BK1515","BK0239","BK1197","BK1606","BK0070","BK0012","BK0183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625561913","title":"每周股票复盘:白云山(600332)2025年净利增5.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2625561913","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625561913?lang=zh_cn&edition=full","pubTime":"2026-04-05 03:12","pubTimestamp":1775329933,"startTime":"0","endTime":"0","summary":"截至2026年4月3日收盘,白云山报收于23.03元,较上周的22.96元上涨0.3%。本周,白云山4月2日盘中最高价报23.25元。本周关注点来自业绩披露要点:2025年归母净利润约为29.83亿元,同比增长5.21%。2025年经营活动现金流净额同比下降,主因下属企业货款回收下降,同时采购支付金额增加。2025年国内销售额70,120万元,白云山制药总厂销售收入2,274万元,研发费用约1.43万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040500000887.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0096","BK1191","BK0012","BK1521","BK0070","BK0097","BK0188","BK0183","BK1197","600332","BK0239","BK0196","BK1515","00874","BK0028","BK1606","BK0175"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624947663","title":"白云山:公司已聘请第三方机构探索制定薪酬绩效优化方案","url":"https://stock-news.laohu8.com/highlight/detail?id=2624947663","media":"证券日报","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624947663?lang=zh_cn&edition=full","pubTime":"2026-04-03 22:19","pubTimestamp":1775225940,"startTime":"0","endTime":"0","summary":"证券日报网4月3日讯,白云山在接受调研者提问时表示,公司已聘请第三方机构,结合公司实际发展需求,探索制定薪酬绩效优化方案,进一步激发人才动力,加强人才队伍建设;同时,积极探索适合公司或下属企业发展的改革方案,探索开展混改、职业经理人机制等创新性举措,同时支持符合条件的下属企业探索开展股权激励、员工持股等,进一步激发下属子公司发展活力。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202604033695294621.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1521","BK0028","BK0175","BK1197","BK0012","600332","BK0070","BK0239","BK0096","BK0183","BK0097","BK0196","00874","BK1515","BK1191","BK0188","BK1606"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624922663","title":"白云山:未来五年公司将坚持现代化、科技化、数字化、国际化发展方向","url":"https://stock-news.laohu8.com/highlight/detail?id=2624922663","media":"证券日报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624922663?lang=zh_cn&edition=full","pubTime":"2026-04-03 22:19","pubTimestamp":1775225940,"startTime":"0","endTime":"0","summary":"证券日报网4月3日讯,白云山在接受调研者提问时表示,未来五年,公司将坚持现代化、科技化、数字化、国际化发展方向,在推动现代中药、化药科技、天然饮品、医药商业四大基石业务板块提质增效的同时,积蓄动能,培育促进消费健康、生物创新、医疗服务等业务发展,推动公司实现高质量发展。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202604033695291745.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK0096","600332","BK0097","BK0012","BK0175","BK0183","BK1197","BK1521","BK1515","BK0196","BK1606","BK1191","BK0070","BK0239","BK0188","00874","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624655215","title":"营收微增难掩现金流“失血”:广药白云山隐现三大结构性风险","url":"https://stock-news.laohu8.com/highlight/detail?id=2624655215","media":"新浪证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624655215?lang=zh_cn&edition=full","pubTime":"2026-04-03 16:37","pubTimestamp":1775205420,"startTime":"0","endTime":"0","summary":"近日,广药集团旗下上市公司白云山发布了2025年年报。表面上看,公司实现了营收与净利润的双增长:全年营收776.56亿元,同比增长3.55%;归母净利润29.83亿元,同比增长5.21%,似乎正在从上一年的业绩低谷中缓慢修复。经营性现金流转负、高毛利业务增长乏力、研发投入萎缩,共同构成了白云山当前面临的三大结构性风险。年报披露后,公司股价的大幅下挫,正是市场对其经营质量与增长可持续性投下的“不信任票”。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/aigcy/2026-04-03/doc-inhtferc8902395.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["00874","600332","159399"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624039425","title":"小摩增持白云山(00874)约14.39万股 每股作价约16.89港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2624039425","media":"智通财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624039425?lang=zh_cn&edition=full","pubTime":"2026-04-02 18:58","pubTimestamp":1775127530,"startTime":"0","endTime":"0","summary":"3月30日,小摩增持白云山(00874)14.3924万股,每股作价16.8915港元,总金额约为243.11万港元。","market":"fut","thumbnail":"https://img.zhitongcaijing.com/image/20260402/20260402184617_46171.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20260402/20260402184617_46171.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1424700.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["LU2357305700.SGD","LU0345769128.USD","BK4585","LU0943347566.SGD","LU2746668974.SGD","BK0012","BK0097","BK0239","LU1551013342.USD","LU0238689110.USD","LU2552382058.USD","LU0006306889.USD","LU2211815571.USD","IE000M9KFDE8.USD","JPMO","600332","LU0323591593.USD","IE0034235295.USD","IE00BLSP4452.SGD","LU0203347892.USD","BK0196","LU1917777945.USD","LU2237443895.HKD","LU2430703251.USD","00874","BK0070","EWH","LU1629891620.HKD","BK4588","IE0034235303.USD","LU1064131342.USD","LU2264538146.SGD","LU0070302665.USD","BK1515","BK4581","LU0640476718.USD","LU1145028129.USD","LU1670628061.USD","SG9999002232.USD","LU2430703095.HKD","IE00BJTD4N35.SGD","LU0170899867.USD","LU1363072403.SGD","LU0211327993.USD","LU0882574139.USD","BK4566","LU1084165304.USD","LU2756315664.SGD","LU1244550221.USD","LU0208291251.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624597874","title":"白云山(00874):白云山制药总厂获国家药监局核准签发关于骨化三醇软胶囊的《药品补充申请批准通知书》","url":"https://stock-news.laohu8.com/highlight/detail?id=2624597874","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624597874?lang=zh_cn&edition=full","pubTime":"2026-04-01 18:48","pubTimestamp":1775040531,"startTime":"0","endTime":"0","summary":"2026年2月5日,白云山制药总厂向国家药监局递交药品上市持有人变更申请,于2026年3月4日获得受理。本次获得骨化三醇软胶囊的《药品补充申请批准通知书》,扩充了白云山制药总厂产品布局,有利于增强本公司在内分泌治疗药物市场的竞争优势。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1424098.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1606","BK0097","BK0196","600332","00874","BK1197","BK0239","BK1521","BK0028","BK1574","BK1191","BK0096","BK0183","01477","BK0175","BK0070","BK0188","BK0012","BK1515"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.gybys.com.cn","stockEarnings":[{"period":"1week","weight":0.0168},{"period":"1month","weight":-0.0018},{"period":"3month","weight":-0.1254},{"period":"6month","weight":-0.1634},{"period":"1year","weight":0.0357},{"period":"ytd","weight":-0.0435}],"compareEarnings":[{"period":"1week","weight":0.0173},{"period":"1month","weight":0.0175},{"period":"3month","weight":-0.0337},{"period":"6month","weight":-0.0268},{"period":"1year","weight":0.1188},{"period":"ytd","weight":0.028}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"广州白云山医药集团股份有限公司是一家主要从事医药健康业务的中国公司。该公司通过四个分部运营。大南药分部从事中西成药、化学原料药、生物医药和天然药物等的研发、制造与销售。大健康分部从事饮料、食品、保健品等产品的生产、研发与销售。大商业分部从事医药产品、医疗器械、保健品等的批发、零售与进出口业务。大医疗分部从事医疗服务、中医养生、现代养老以及医疗器械产业的投资。该公司主要在中国国内和海外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.428571,"avgChangeRate":-0.009902},{"month":2,"riseRate":0.714286,"avgChangeRate":0.058504},{"month":3,"riseRate":0.586207,"avgChangeRate":0.049388},{"month":4,"riseRate":0.62069,"avgChangeRate":0.081935},{"month":5,"riseRate":0.586207,"avgChangeRate":0.047509},{"month":6,"riseRate":0.5,"avgChangeRate":0.021373},{"month":7,"riseRate":0.428571,"avgChangeRate":-0.016161},{"month":8,"riseRate":0.392857,"avgChangeRate":-0.036785},{"month":9,"riseRate":0.428571,"avgChangeRate":-0.010651},{"month":10,"riseRate":0.428571,"avgChangeRate":0.003937},{"month":11,"riseRate":0.448276,"avgChangeRate":0.008347},{"month":12,"riseRate":0.535714,"avgChangeRate":0.023788}],"exchange":"SEHK","name":"白云山","nameEN":"BAIYUNSHAN PH"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"白云山(00874)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供白云山(00874)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"白云山,00874,白云山股票,白云山股票老虎,白云山股票老虎国际,白云山行情,白云山股票行情,白云山股价,白云山股市,白云山股票价格,白云山股票交易,白云山股票购买,白云山股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"白云山(00874)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供白云山(00874)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}